Dirceu Barbano confirmed as head of Anvisa
This article was originally published in RAJ Devices
Dirceu Br�s Aparecido Barbano has been confirmed as director-president of the Brazilian healthcare products regulatory agency Anvisa (Agência Nacional de Vigilância Sanit�ria). He has held this role in a caretaker capacity since January, when his predecessor, clinical analyst Dirceu Raposo de Mello, stepped down after six years at the helm. Mr Barbano joined the Brasilia-based agency as a director in October 2008, with a background specialising in pharmacy.
During Mr Barbano's period as caretaker leader, he has overseen important medtech sector initiatives, including: the strengthening of surveillance ties with China's State Food and Drug Administration; the ongoing reform of pathology laboratory services; and the passage of legislation guaranteeing better access to medtech and medicines, subject to product selection criteria.